Saad Rehman
Interventional Cardiology · Nashville, TNNPI 1861984916
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Abbott at 27.1% of the total.
Across 370 payments — averaging $64.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Boston Scientific$5K
- Medtronic$3K
- Edwards Lifesciences$2K
- Penumbra, Inc.$1K
- Abiomed$1K
- plus $6K from 33 others
What the payments were for
- Grants$2,0008%
- Travel & lodging$7,96033%
- Food & beverage$13,15955%
- Education$6483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 79 | $6,443 |
| Boston Scientific | 42 | $4,573 |
| Medtronic | 22 | $3,249 |
| Edwards Lifesciences | 20 | $1,665 |
| Penumbra, Inc. | 7 | $1,250 |
| Abiomed | 20 | $1,073 |
| Inari Medical, Inc. | 7 | $929 |
| Actelion Pharmaceuticals US, Inc. | 27 | $673 |
| Sanofi-aventis U.S. LLC | 10 | $419 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $410 |
| Novartis | 21 | $405 |
| Pfizer | 22 | $401 |
| Amgen | 16 | $266 |
| Cardiva Medical, Inc. | 9 | $254 |
| AstraZeneca | 11 | $197 |
| W. L. Gore & Associates, Inc. | 3 | $186 |
| Cardiovascular Systems Inc. | 1 | $180 |
| Livanova USA, Inc. | 1 | $152 |
| Astellas Pharma US Inc | 3 | $142 |
| Philips North America LLC | 1 | $111 |
| Bayer | 4 | $99 |
| Bridgebio Pharma, Inc. | 3 | $98 |
| Chiesi USA, Inc. | 5 | $81 |
| Johnson & Johnson | 5 | $65 |
| Shockwave Medical, Inc | 3 | $57 |
| Impulse Dynamics (USA) Inc. | 2 | $46 |
| Cordis US CORP. | 2 | $45 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $41 |
| AbbVie | 1 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $33 |
| Cvrx, Inc. | 1 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $19 |
| Heartflow, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERA$1,384
- OPTIS$925
- FLOWTRIEVER CATHETER, S$883
- RUBY Coil$843
- PASCAL$832
- ESPRIT$762
- CT THROMBECTOMY SYSTEM KIT$660
- Impella$508
- ACCULINK$456
- Perclose ProStyle$410
- ONYX FRONTIER$399
- Ranger$387
- Indigo System$293
- GENERAL ANGIOGRAPHY$272
- COREVALVE EVOLUT R$248
- Diamondback Peripheral$180
- JETSTREAM SC$177
- TandemHeart$152
- GORE CARDIOFORM Septal Occluder$150
- RESOLUTE ONYX$149
How this compares
$23,767 in reported general payments places this provider in the 75th percentile of 207 interventional cardiology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 19 | $14,780 |
| ClopidogrelClopidogrel Bisulfate | 54 | $1,503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $197 | $14,78019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 207 interventional cardiology providers in Tennessee.
Other interventional cardiology in Nashville
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
- Michael MorseNashville$353K
- Nadia SuttonNashville$344K
- Samuel HorrNashville$246K
- Colin BarkerNashville$217K
- Leah RajNashville$88K
- Andrew GoodmanNashville$57K
- Jay PatelNashville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.